Showing 1 - 10 of 188
Persistent link: https://www.econbiz.de/10005239300
Persistent link: https://www.econbiz.de/10005293430
We assess the relationship between business cycles and mortality risk using a large individual level data set on over 40,000 individuals in Sweden who were followed for 10-16 years (leading to over 500,000 person-year observations). We test the effect of six alternative business cycle indicators...
Persistent link: https://www.econbiz.de/10008589009
We test whether mortality is related to individual income, mean community income, and community income inequality, controlling for initial health status and personal characteristics. The analysis is based on a random sample from the adult Swedish population of more than 40,000 individuals who...
Persistent link: https://www.econbiz.de/10005010019
Persistent link: https://www.econbiz.de/10005052973
This paper investigates the effects of changes in drug therapy on drug expenditure in Sweden between 1990 and 1995. Analyses have been carried out for both the aggregate drug expenditure and for drug expenditure according to the main groups of the Anatomical Therapeutic Chemical (ATC)...
Persistent link: https://www.econbiz.de/10005449148
We estimate the income-related inequality in Sweden with respect to life-years and quality-adjusted life-years (QALYs). We use a large data-set from Sweden with over 40,000 individuals followed up for 10-16 years, to estimate the survival and quality-adjusted survival in different income groups....
Persistent link: https://www.econbiz.de/10005649496
In this paper we estimate a "Grossman" model of demand for health based on Swedish micro data. The data set consists of a random sample of over 5000 individuals taken from the Swedish adult population. Health capital is measured by a categorical measure of overall health status, and an ordered...
Persistent link: https://www.econbiz.de/10008613552
In recent work on international comparisons of income-related inequalities in health, the concentration index has been used as a measure of health inequality. A drawback of this measure is that it is sensitive to whether it is estimated with respect to health or morbidity. An alternative would...
Persistent link: https://www.econbiz.de/10008616042
Persistent link: https://www.econbiz.de/10005239314